Efficacy study of early presumptive therapy (EPT) for deep fungal infection

Japanese Journal of Medical Mycology

Volumn 45, Issue 4, 2004, Pages 203-208

  Tanaka, Hideharu ^a   Goto, Hideaki ^a   Sakaki, Seiki ^a   Yoshinari, Kiyoshi ^a   Yoshizawa, Mie ^a   Shimazaki, Syuji ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Critical care medicine; Deep fungal infection; EPT

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

BURN; CANDIDA; COHORT ANALYSIS; COMA; CRITICAL ILLNESS; DEEP FUNGAL INFECTION; DISEASE SEVERITY; DRUG EFFICACY; EARLY PRESUMPTIVE THERAPY; ENTEROBACTER; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE TRAUMA; MYCOSIS; NEISSERIA; NONHUMAN; PNEUMONIA; PSEUDOMONAS; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS AUREUS; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

CANDIDA; ENTEROBACTER; ESCHERICHIA COLI; FUNGI; NEISSERIA; PSEUDOMONAS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 10044243401     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.45.203     Document Type: Review

References (20)

1. Chitkara YK, Feierabend TC: Endogenous and exogenous infections with Pseudomonas aeruginosa in a bum unit. Int Surg 66: 237-240, 1981.
2. Border JR: Trauma and sepsis, in Worth MH (eds) : Principles and Practice of Trauma Care. Baltimore Williams & Wilkins, pp.330-387, 1982.
3. Vincent JL, Bihari DJ, Suter PM, et al.: The prevalence of nosocomial infection in intensive care units in Europe: Results of the European prevalence of infection in intensive care (EPIC) study. JAMA 274: 639-644, 1995.
4. Dean DA, Burchard KW: Fungal Infection in surgical patients. Am J Surg 171: 374-382, 1996.
5. Maejima K, Deitch EA, Burg RD: Bacterial translocation from the gastrointestinal tract of rats receiving thermal injury. Infect Immun 43: 6-10, 1984.
6. Alexander JW, Boice ST, Babcock GF, et al.: The process or microbial translocation. Ann Surg 212: 496-512, 1990.
7. Solomkin JS, Flohr A, Simmons RL: Indications for therapy fungemia in postoperative patients. Arch Surg 117: 1272-1275, 1982.
8. Wey SB, Mori M, Pfaller MA, et al.: Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 149: 2349-2353, 1989.
9. Berg RD, Garlington AW: Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 23: 403-411, 1979.
10. Maejima K, Deitch EA, Berg R: Promotion by burn stress of the translocation of bacteria from the gastrointestinal tracts of mice. Arch Surg 119: 166-172, 1984.
11. British Society for Antimicrobial Chemotherapy Working Party: Management of deep Candida infection in surgical and intensive care unit patients. Intens Care Med 20: 522-528, 1994.
12. Demajo WA, JG Guimond F, Rotstein C, et al.: Guideline for the management of nosocomial Candida infections in non-neutropenic intensive care patients. Canadian J Inf Dis 8(Suppl. B): 3B-9B, 1997.
13. Pittet D, Monod M, Suter PM, et al.: Candida colonization and subsequent infections on critically ill surgical patients. Ann Surg 220: 751-758, 1994.
14. Wey SB, Motomi M, Pfaller MA, et al.: Hospital-acquired candidemia; The attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645, 1988.
15. Aikawa N, Sumiyama Y, Kusachi S, et al.: Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan. J Infect Chemother 8: 237-241, 2002.
16. Dube MP, Heseltine PNR, Rinaldi MG, et al.: Fungemia and colonization with nystain-resistant Candida rugosa in a burn unit. Clin Infec Dis 18: 77-82, 1994.
17. Obayashi T, Yoshida M, Mori T, et al.: Plasma (1-3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episords. Lancet 345: 17-20, 1995.